Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-248586
Filing Date
2020-09-18
Accepted
2020-09-18 07:12:29
Documents
6
Period of Report
2020-09-18

Document Format Files

Seq Description Document Type Size
1 6-K d58139d6k.htm 6-K 16798
2 EX-1.1 d58139dex11.htm EX-1.1 193470
3 EX-5.1 d58139dex51.htm EX-5.1 72524
4 EX-99.1 d58139dex991.htm EX-99.1 13096
5 GRAPHIC g58139g32m02.jpg GRAPHIC 3965
6 GRAPHIC g58139g34e12.jpg GRAPHIC 4270
  Complete submission text file 0001193125-20-248586.txt   308678
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 201182744
SIC: 2836 Biological Products, (No Diagnostic Substances)